Cara Therapeutics | Capital Ordinário

Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 16K 0 2023-12
Cassava Sciences USD 42K 0 2023-09
Clal Biotechnology ILS 1.61M 0 2022-12
CSL USD 517M 4.48B 2023-06
Grifols EUR 119.6M 0 2023-09
Halozyme Therapeutics USD 127K 5K 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Pacira USD 46K 0 2023-12
Pfizer USD 478M 0 2023-09
RedHill Biopharma USD 4.62M 1.78M 2023-06
Supernus Pharmaceuticals USD 55K 0 2023-12



Cara Therapeutics Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.